Search

everythinglearnresearchcommunity

for

Search:↓

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

3% topical minoxidil effectively treats extensive alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Mogamulizumab can cause hair loss and skin rashes.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

New genetic discoveries may lead to better treatments for alopecia areata.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Most children treated with diphencyprone regrew some or all of their hair.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Microneedling with clobetasol cream works better for hair regrowth in alopecia areata than clobetasol cream alone.